急性视网膜坏死：目前伐昔洛韦方案是否足够？
Acute Retinal Necrosis: Is The Current Valacyclovir Regimen Adequate?
机构信息
Department of Ophthalmology and Visual Sciences, Federal University of São Paulo , São Paulo, Brazil.
出版信息
Ocul Immunol Inflamm. 2020 May 18;28(4):665-666. doi: 10.1080/09273948.2019.1616771. Epub 2019 Aug 12.
Abstract
Acute Retinal Necrosis (ARN) is a potentially devastating form of Uveitis. Antivirals are the mainstay treatment for this syndrome. In this letter, we question the current oral Valacyclovir dosage, based on the experience we had with a recent unresponsive ARN case.
摘要
急性视网膜坏死（ARN）是一种潜在破坏性的葡萄膜炎形式。抗病毒药物是治疗这种综合征的主要方法。在这封信中，我们根据最近一个对抗病毒药物 Valacyclovir 治疗反应不佳的 ARN 病例的经验，对目前口服 Valacyclovir 的剂量提出质疑。
Zotero 插件